304 related articles for article (PubMed ID: 33243118)
21. Plant-Based Approaches for Rheumatoid Arthritis Regulation: Mechanistic Insights on Pathogenesis, Molecular Pathways, and Delivery Systems.
Bhoi A; Dwivedi SD; Singh D; Keshavkant S; Singh MR
Crit Rev Ther Drug Carrier Syst; 2024; 41(4):39-86. PubMed ID: 38305341
[TBL] [Abstract][Full Text] [Related]
22. New Rheumatoid Arthritis Treatments for 'Old' Patients: Results of a Systematic Review.
Caporali R; Fakhouri WKH; Nicolay C; Longley HJ; Losi S; Rogai V
Adv Ther; 2020 Sep; 37(9):3676-3691. PubMed ID: 32705531
[TBL] [Abstract][Full Text] [Related]
23. Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.
Prabha J; Kumar M; Kumar D; Chopra S; Bhatia A
Curr Drug Deliv; 2024; 21(8):1082-1105. PubMed ID: 37622715
[TBL] [Abstract][Full Text] [Related]
24. Treatment of rheumatoid arthritis: Unraveling the conundrum.
Zampeli E; Vlachoyiannopoulos PG; Tzioufas AG
J Autoimmun; 2015 Dec; 65():1-18. PubMed ID: 26515757
[TBL] [Abstract][Full Text] [Related]
25. Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis.
Ain Q; Zeeshan M; Khan S; Ali H
J Biomed Mater Res A; 2019 Dec; 107(12):2595-2600. PubMed ID: 31373751
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiology, diagnosis, and herbal medicine-based therapeutic implication of rheumatoid arthritis: an overview.
Kaur C; Mishra Y; Kumar R; Singh G; Singh S; Mishra V; Tambuwala MM
Inflammopharmacology; 2024 Jun; 32(3):1705-1720. PubMed ID: 38528307
[TBL] [Abstract][Full Text] [Related]
27. Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities.
Blackburn WD
Am J Med; 1996 Feb; 100(2A):24S-30S. PubMed ID: 8604723
[TBL] [Abstract][Full Text] [Related]
28. IL-17 as a future therapeutic target for rheumatoid arthritis.
van den Berg WB; Miossec P
Nat Rev Rheumatol; 2009 Oct; 5(10):549-53. PubMed ID: 19798029
[TBL] [Abstract][Full Text] [Related]
29. Core management principles in rheumatoid arthritis to help guide managed care professionals.
Agarwal SK
J Manag Care Pharm; 2011; 17(9 Suppl B):S03-8. PubMed ID: 22073933
[TBL] [Abstract][Full Text] [Related]
30. [New strategies for treatment of rheumatoid arthritis].
Kashiwazaki S
Nihon Rinsho; 1997 Sep; 55(9):2467-75. PubMed ID: 9301317
[TBL] [Abstract][Full Text] [Related]
31. New understanding and approaches to treatment in rheumatoid arthritis.
Tayar JH; Suarez-Almazor ME
Br Med Bull; 2010; 94():201-14. PubMed ID: 20200013
[TBL] [Abstract][Full Text] [Related]
32. Lipid-based Vesicular Nanocargoes as Nanotherapeutic Targets for the Effective Management of Rheumatoid Arthritis.
Rahman M; Beg S; Sharma G; Saini S; Rub RA; Aneja P; Anwar F; Alam MA; Kumar V
Recent Pat Antiinfect Drug Discov; 2016; 11(1):3-15. PubMed ID: 27193030
[TBL] [Abstract][Full Text] [Related]
33. The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis.
He Y; Huang Y; Mai C; Pan H; Luo HB; Liu L; Xie Y
Pharmacol Res; 2020 Nov; 161():105134. PubMed ID: 32798648
[TBL] [Abstract][Full Text] [Related]
34. Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis.
Chen SJ; Lin GJ; Chen JW; Wang KC; Tien CH; Hu CF; Chang CN; Hsu WF; Fan HC; Sytwu HK
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884802
[TBL] [Abstract][Full Text] [Related]
35. Small-molecule therapeutics in rheumatoid arthritis: scientific rationale, efficacy and safety.
Meier FM; McInnes IB
Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):605-24. PubMed ID: 25481553
[TBL] [Abstract][Full Text] [Related]
36. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis.
Lin YJ; Anzaghe M; Schülke S
Cells; 2020 Apr; 9(4):. PubMed ID: 32260219
[TBL] [Abstract][Full Text] [Related]
37. Food-Derived Nanoscopic Drug Delivery Systems for Treatment of Rheumatoid Arthritis.
Han D; Chen Q; Chen H
Molecules; 2020 Jul; 25(15):. PubMed ID: 32752061
[TBL] [Abstract][Full Text] [Related]
38. A mechanistic insight of phytoestrogens used for Rheumatoid arthritis: An evidence-based review.
Chakraborty D; Gupta K; Biswas S
Biomed Pharmacother; 2021 Jan; 133():111039. PubMed ID: 33254019
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
Zhu H; Deng FY; Mo XB; Qiu YH; Lei SF
Pharmacogenomics; 2014 Mar; 15(4):551-66. PubMed ID: 24624921
[TBL] [Abstract][Full Text] [Related]
40. Lipid metabolism and rheumatoid arthritis.
Lei Q; Yang J; Li L; Zhao N; Lu C; Lu A; He X
Front Immunol; 2023; 14():1190607. PubMed ID: 37325667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
